Newsletter Subject

Second Malignancy Risk With CAR T-Cell Therapy on Par With Other Treatments

From

medpagetoday.com

Email Address

daily.headlines@broadcaster3.medpagetoday.com

Sent On

Wed, Sep 11, 2024 10:44 PM

Email Preheader Text

Daily Headlines Wednesday, September 11, 2024 Today's Top Stories for {NAME} THE BREAK ROOM CME SPOT

[MEDPAGE TODAY]( Daily Headlines Wednesday, September 11, 2024 Today's Top Stories for {NAME} [ONCOLOGY/HEMATOLOGY]( [Second Malignancy Risk With CAR T-Cell Therapy on Par With Other Treatments]( [MEETING COVERAGE]( [Cheap Antidepressant Flops for Severe Breathlessness in Trial]( [TRANSPLANTATION]( [Threats to Whistleblowers, Rampant Fraud Plague Transplant System, Lawmakers Told]( THE BREAK ROOM [Spell Check-Up: Try to Pass This Spelling Quiz]( CME SPOTLIGHT [Moving the Needle: Adopting New Evidence Into the Lower-Risk Myelodysplastic Syndrome Treatment Paradigm]( [INFECTIOUS DISEASE]( [Circulating H5N1 Bird Flu Spotted by Wastewater Monitoring During Summer]( [PSYCHIATRY]( [Inpatient CBT Reduces Suicide and Readmissions After Discharge]( THE BREAK ROOM [Play Today’s Wordosis]( ADVERTISEMENT [MEETING COVERAGE]( [Microvascular Diabetes Complications Linked to Moderate/Severe Gum Disease]( CME SPOTLIGHT [Reeling in Complement: Casting a Wider Net to Recognize and Manage Paroxysmal Nocturnal Hemoglobinuria]( [POP MEDICINE]( [Is There a Surgical Shortcut to Six-Pack Abs?]( [MEETING COVERAGE]( [Antibody Drug-Conjugate Shows Promising Activity in Extensive-Stage SCLC]( [INFECTIOUS DISEASE]( [Molnupiravir May Offer Modest 6-Month Benefits for High-Risk COVID Patients]( THE BREAK ROOM [Wordectomy: Guess Today’s Medical Condition]( CME SPOTLIGHT [Expert Strategies for Recognition and Management of Adverse Events of Bispecific Antibodies in Relapsed/Refractory Diffuse Large B-Cell Lymphoma]( [ONCOLOGY/HEMATOLOGY]( [Limits to Anti-Nausea Pill Coverage Wear on Cancer Patients and Doctors]( [GASTROENTEROLOGY]( [FDA Reviewers Skeptical of Ocaliva for Rare Bile Duct Disease]( [POP MEDICINE]( [Thanks to Reddit, a New Diagnosis Is Bubbling Up Across the Nation]( CME SPOTLIGHT [The Role of Neurology Care Teams in Caring for Patients With Multiple Myeloma Receiving Bispecific Antibodies]( [PSYCHIATRY]( [Local Suicide Risk Factors; Chappell Roan's Bipolar II Disorder; Student Mindfulness]( [PERSPECTIVES]( [Never Forget the 9/11 Responders Who Risked Their Lives]( [OB/GYN]( [What to Know About the Investigation Into Florida's Abortion Ballot Initiative]( CME SPOTLIGHT [Navigating Endocrine Resistance: Latest Strategies in HR+/HER2- Breast Cancer Care]( [AAD READING ROOM]( [Five-Millimeter Margins Suitable for Low-Risk Melanoma Excisions]( [WASHINGTON WATCH]( [Abortion, COVID, and Obamacare Highlighted in Trump-Harris Debate]( [MEETING COVERAGE]( [Liraglutide Helped Cut BMI in Kids With Obesity as Young as 6]( CME SPOTLIGHT [Elevating Treatment Selection and Sequencing in Multiple Myeloma: Personalized Decisions Through Lines of Therapy]( # Weekly Survey [Beef Up Regulation on 'Wellness' Industry?]( The growth of the $5.6 trillion global wellness industry has led to [calls for greater government regulation]( of supplement makers and medical test companies[VOTE >]( Meeting Coverage Can't get away? MedPage Today brings you extensive coverage of more than 80 meetings in a wide range of specialties. [SEE ALL STORIES >]( Got a news tip? MedPage Today offers several ways to provide information to our journalists securely and confidentially. [LEARN MORE >]( [EVERYDAY HEALTH]( © 2024 MedPage Today, LLC. MedPage Today is among the federally registered trademarks of MedPage Today, LLC, and may not be used by third parties without explicit permission. You have received this email because you have registered to receive emails at www.medpagetoday.com, with the email address: {EMAIL} [Manage Email Preferences]( | [Unsubscribe](lst=NL_Daily_DHE?xid=nl_mpt_DHE_2024-09-11&mh=3c4cdd242849aa0e970f25e401732f81) | [Terms of Use]( | [Privacy Policy]( Technical Questions: feedback@medpagetoday.com 114 5th Avenue, 15th Floor New York, NY 10011

Marketing emails from medpagetoday.com

View More
Sent On

08/12/2024

Sent On

08/11/2024

Sent On

07/11/2024

Sent On

07/11/2024

Sent On

06/11/2024

Sent On

04/11/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2025 SimilarMail.